CONGENITAL DYSERYTHROPOIETIC ANEMIA (CDA)
Clinical trials for CONGENITAL DYSERYTHROPOIETIC ANEMIA (CDA) explained in plain language.
Never miss a new study
Get alerted when new CONGENITAL DYSERYTHROPOIETIC ANEMIA (CDA) trials appear
Sign up with your email to follow new studies for CONGENITAL DYSERYTHROPOIETIC ANEMIA (CDA), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a common bone drug help rare anemia patients?
Disease control Recruiting nowThis early study tests whether zoledronic acid, a drug usually used for bone health, can improve anemia in adults with congenital dyserythropoietic anemia (CDA), a rare inherited blood disorder. Only 2 participants will receive the drug intravenously every 4 weeks for 4 doses. Th…
Matched conditions: CONGENITAL DYSERYTHROPOIETIC ANEMIA (CDA)
Phase: PHASE1, PHASE2 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated May 17, 2026 00:59 UTC
-
New diagnostic approach could personalize care for rare blood disorders
Diagnosis Recruiting nowThis study aims to improve how doctors diagnose sickle cell disease and other rare anemias by combining advanced blood tests with genetic analysis. Researchers will enroll 200 people with confirmed or suspected rare anemia to see if a new test can predict disease severity. The go…
Matched conditions: CONGENITAL DYSERYTHROPOIETIC ANEMIA (CDA)
Sponsor: Hospital Universitari Vall d'Hebron Research Institute • Aim: Diagnosis
Last updated May 15, 2026 11:53 UTC